Literature DB >> 28545932

The association between tau PET and retrospective cortical thinning in clinically normal elderly.

Molly R LaPoint1, Jasmeer P Chhatwal1, Jorge Sepulcre2, Keith A Johnson3, Reisa A Sperling4, Aaron P Schultz1.   

Abstract

Tau pathology has been associated with neuronal loss at autopsy, but the temporal evolution of tau pathology and atrophy remains unclear. Here, we investigate the association between cross-sectional AV-1451-PET as a marker of tau pathology and cortical thickness cross-sectionally. We also investigated retrospective rates of cortical thinning over the three years preceding the AV-1451 scan in a clinically normal cohort of 103 older adults from the Harvard Aging Brain Study. Tau measurements were Geometric Transfer Matrix partial volume corrected standardized uptake value ratios (SUVRs) with a cerebellar gray reference region. Thirty-four FreeSurfer-defined cortical regions of interest (ROIs) were used for both thickness and AV-1451 in each hemisphere, with seven additional volumetric ROIs. We examined "local" relationships between AV-1451 and cortical thickness in the same ROI, as well as inferior temporal AV-1451 and all thickness ROIs. All models included baseline age and sex, both interacting with time in retrospective longitudinal models, as covariates. Cross-sectional models controlled for the number of days between the two scans. Cross-sectional local comparisons revealed significant associations between elevated AV-1451 and thinner cortical ROIs predominantly in temporal regions, while analyses associating inferior temporal AV-1451 with all cortical ROIs showed a widespread pattern of significant relationships, which was strongest in temporal and parietal cortices. In our retrospective longitudinal analyses, we saw significant relationships in temporal and parietal regions. Significant local relationships were seen in right superior temporal, middle temporal, temporal pole, and fusiform, as well as the left cuneus and banks of the left superior temporal sulcus. Significant relationships between inferior temporal AV-1451 and faster thinning were observed in right temporal regions (middle temporal and fusiform) and bilateral parahippocampal cortices. We observed significant negative relationships between local and inferior temporal AV-1451 signal and both cross-sectional cortical thickness and rates of thinning in lateral and medial temporal regions. This is an important early step toward elucidating the relationship between tau pathology and retrospective longitudinal atrophy in aging and preclinical AD.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Alzheimer's disease; Atrophy; Longitudinal; Neurodegeneration; Tau

Mesh:

Substances:

Year:  2017        PMID: 28545932      PMCID: PMC5772972          DOI: 10.1016/j.neuroimage.2017.05.049

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  55 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

2.  3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

Authors:  Liana G Apostolova; Kristy S Hwang; John P Andrawis; Amity E Green; Sona Babakchanian; Jonathan H Morra; Jeffrey L Cummings; Arthur W Toga; John Q Trojanowski; Leslie M Shaw; Clifford R Jack; Ronald C Petersen; Paul S Aisen; William J Jagust; Robert A Koeppe; Chester A Mathis; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

3.  The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease.

Authors:  T Tapiola; M Overmyer; M Lehtovirta; S Helisalmi; J Ramberg; I Alafuzoff; P Riekkinen; H Soininen
Journal:  Neuroreport       Date:  1997-12-22       Impact factor: 1.837

4.  CSF tau markers are correlated with hippocampal volume in Alzheimer's disease.

Authors:  Leonardo C de Souza; Marie Chupin; Foudil Lamari; Claude Jardel; Delphine Leclercq; Olivier Colliot; Stéphane Lehéricy; Bruno Dubois; Marie Sarazin
Journal:  Neurobiol Aging       Date:  2011-04-13       Impact factor: 4.673

5.  Within-subject template estimation for unbiased longitudinal image analysis.

Authors:  Martin Reuter; Nicholas J Schmansky; H Diana Rosas; Bruce Fischl
Journal:  Neuroimage       Date:  2012-03-10       Impact factor: 6.556

6.  Dynamics of gray matter loss in Alzheimer's disease.

Authors:  Paul M Thompson; Kiralee M Hayashi; Greig de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David Herman; Michael S Hong; Stephanie S Dittmer; David M Doddrell; Arthur W Toga
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

7.  Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.

Authors:  Liang Wang; Tammie L Benzinger; Yi Su; Jon Christensen; Karl Friedrichsen; Patricia Aldea; Jonathan McConathy; Nigel J Cairns; Anne M Fagan; John C Morris; Beau M Ances
Journal:  JAMA Neurol       Date:  2016-09-01       Impact factor: 18.302

8.  Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

Authors:  Michael J Pontecorvo; Michael D Devous; Michael Navitsky; Ming Lu; Stephen Salloway; Frederick W Schaerf; Danna Jennings; Anupa K Arora; Anne McGeehan; Nathaniel C Lim; Hui Xiong; Abhinay D Joshi; Andrew Siderowf; Mark A Mintun
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

9.  Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease.

Authors:  Matthew R Brier; Brian Gordon; Karl Friedrichsen; John McCarthy; Ari Stern; Jon Christensen; Christopher Owen; Patricia Aldea; Yi Su; Jason Hassenstab; Nigel J Cairns; David M Holtzman; Anne M Fagan; John C Morris; Tammie L S Benzinger; Beau M Ances
Journal:  Sci Transl Med       Date:  2016-05-11       Impact factor: 17.956

Review 10.  A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Howard H Feldman; Giovanni B Frisoni; Harald Hampel; William J Jagust; Keith A Johnson; David S Knopman; Ronald C Petersen; Philip Scheltens; Reisa A Sperling; Bruno Dubois
Journal:  Neurology       Date:  2016-07-01       Impact factor: 9.910

View more
  47 in total

1.  Structure-function multi-scale connectomics reveals a major role of the fronto-striato-thalamic circuit in brain aging.

Authors:  Paolo Bonifazi; Asier Erramuzpe; Ibai Diez; Iñigo Gabilondo; Matthieu P Boisgontier; Lisa Pauwels; Sebastiano Stramaglia; Stephan P Swinnen; Jesus M Cortes
Journal:  Hum Brain Mapp       Date:  2018-07-13       Impact factor: 5.038

Review 2.  Imaging the evolution and pathophysiology of Alzheimer disease.

Authors:  William Jagust
Journal:  Nat Rev Neurosci       Date:  2018-11       Impact factor: 34.870

3.  Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake.

Authors:  Sandhitsu R Das; Long Xie; Laura E M Wisse; Ranjit Ittyerah; Nicholas J Tustison; Bradford C Dickerson; Paul A Yushkevich; David A Wolk
Journal:  Neurobiol Aging       Date:  2018-02-09       Impact factor: 4.673

4.  The effect of white matter hyperintensities on cognition is mediated by cortical atrophy.

Authors:  Batool Rizvi; Atul Narkhede; Briana S Last; Mariana Budge; Giuseppe Tosto; Jennifer J Manly; Nicole Schupf; Richard Mayeux; Adam M Brickman
Journal:  Neurobiol Aging       Date:  2017-12-16       Impact factor: 4.673

5.  Preserved Structural Network Organization Mediates Pathology Spread in Alzheimer's Disease Spectrum Despite Loss of White Matter Tract Integrity.

Authors:  Fon Powell; Duygu Tosun; Roksana Sadeghi; Michael Weiner; Ashish Raj
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Early Tau Burden Correlates with Higher Rate of Atrophy in Transentorhinal Cortex.

Authors:  Long Xie; Sandhitsu R Das; Laura E M Wisse; Ranjit Ittyerah; Paul A Yushkevich; David A Wolk
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.

Authors:  Brian A Gordon; Tyler M Blazey; Jon Christensen; Aylin Dincer; Shaney Flores; Sarah Keefe; Charles Chen; Yi Su; Eric M McDade; Guoqiao Wang; Yan Li; Jason Hassenstab; Andrew Aschenbrenner; Russ Hornbeck; Clifford R Jack; Beau M Ances; Sarah B Berman; Jared R Brosch; Douglas Galasko; Serge Gauthier; James J Lah; Mario Masellis; Christopher H van Dyck; Mark A Mintun; Gregory Klein; Smiljana Ristic; Nigel J Cairns; Daniel S Marcus; Chengjie Xiong; David M Holtzman; Marcus E Raichle; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

8.  Relationships Between Tau and Glucose Metabolism Reflect Alzheimer's Disease Pathology in Cognitively Normal Older Adults.

Authors:  Jenna N Adams; Samuel N Lockhart; Lexin Li; William J Jagust
Journal:  Cereb Cortex       Date:  2019-05-01       Impact factor: 5.357

9.  Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.

Authors:  Salvatore Spina; Jesse A Brown; Jersey Deng; Raquel C Gardner; Alissa L Nana; Ji-Hye L Hwang; Stephanie E Gaus; Eric J Huang; Joel H Kramer; Howie J Rosen; John Kornak; John Neuhaus; Bruce L Miller; Lea T Grinberg; Adam L Boxer; William W Seeley
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

10.  Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.

Authors:  Matthew R Scott; Olivia L Hampton; Rachel F Buckley; Jasmeer P Chhatwal; Bernard J Hanseeuw; Heidi Il Jacobs; Michael J Properzi; Justin S Sanchez; Keith A Johnson; Reisa A Sperling; Aaron P Schultz
Journal:  Neuroimage       Date:  2020-06-05       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.